Oct 302025

Women in Privacy – Global Privacy Leadership Lunch

Data Matters Contributors
, , ,

Join us in Brussels for our next Women in Privacy – Global Privacy Leadership Lunch.

Hilton Grand Place | Brussels, Belgium

12:30 p.m. — 2:00 p.m. CET

Wednesday, November 19, 2025

RSVP here.

The lunch will feature a panel discussion with:

  • Lara Liss, Chief Privacy and Data Trust Officer, GE HealthCare
  • Tina Maisonneuve, Chief Privacy and Data Trust Officer, Aon
  • Giorgia Vulcano, Legal and Corporate Affairs – Sr. Manager, AB InBev

This engaging session will focus on practical tips for optimizing the approval process for AI tools and use cases. More than just a discussion, this event is a chance to connect with peers who are navigating similar challenges. Share insights, exchange ideas, and build valuable relationships as we explore how to move from bottlenecks to green lights in AI adoption.

Agenda

Registration/Networking Lunch: 12:30 p.m. CET
Program: 1:00 p.m. — 2:00 p.m. CET

All are invited to attend this event.

Please note, due to space limitation for this event, registrations will be reviewed and confirmed by email in due course.

This post is as of the posting date stated above. Sidley Austin LLP assumes no duty to update this post or post about any subsequent developments having a bearing on this post.

Data Matters Contributors

sidleyprivacyblog@sidley.com

You might also like
Data Protection in Financial Services Week 2025 – Webinar Recordings Now Live

Data Protection in Financial Services (DPFS) Week 2025 consisted of a series of webinars featuring industry leaders who offered invaluable insights on balancing AI with privacy, cybersecurity, and regulatory challenges within the financial services industry. DPFS Week was relevant to all those in financial services, including those in banking, insurance, fintech, funds, payments, private equity, securities, wealth management, and other sectors.

U.S. FDA and CMS Actions on Generative AI-Enabled Mental Health Devices Yield Insights Across AI Product Development

Industry is increasingly exploring the use of AI chatbots to potentially diagnose and treat various medical conditions, including in the area of mental health. FDA is just beginning to develop its regulatory framework for approved, cleared, or authorized devices in the mental health space based on generative AI technology. The medtech industry, healthcare providers, and the public are closely watching FDA developments and guidance regarding the use of generative AI across the medical device space.

The UK’s First Copyright vs. AI Decision: Key Takeaways on a Win for the AI Industry

The UK’s first “Copyright vs. AI” decision (Getty Images (US) Inc & ors vs. Stability AI Limited [2025] EWHC 2863 (Ch)) marks a clear win for the artificial intelligence industry. The English High Court raised the rhetorical question on the industry’s lips, “whether this judgment will, in reality, have anything to say on the balance to be struck between the two warring factions…”.  The Judge’s answer is clear: the case does not answer whether training and development of AI models in the UK is an indefensible infringement of copyright. As to deployment of that trained model, the High Court concluded that an AI model itself cannot constitute an infringing copy. On Stability AI’s reproduction of the Getty trademarks, the High Court found that there was a historic and limited infringement.